257 related articles for article (PubMed ID: 20496166)
1. No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects.
Ma Y; Yang J; Liu Z; Zhang P; Yang Z; Wang Y; Qin H
Breast Cancer Res Treat; 2011 Jan; 125(1):201-5. PubMed ID: 20496166
[TBL] [Abstract][Full Text] [Related]
2. The association of SULT1A1 codon 213 polymorphism and breast cancer susceptibility: meta-analysis from 16 studies involving 23,445 subjects.
Sun Y; Zang Z; Xu X; Zhang Z; Zhong L; Zan W; Zhao Y; Sun L
Breast Cancer Res Treat; 2011 Jan; 125(1):215-9. PubMed ID: 20505990
[TBL] [Abstract][Full Text] [Related]
3. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
Yao L; Yu X; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(2):503-7. PubMed ID: 20052535
[TBL] [Abstract][Full Text] [Related]
4. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
5. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
6. Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case-control study.
He XF; Su J; Zhang Y; Huang X; Liu Y; Ding DP; Wang W; Arparkorn K
Breast Cancer Res Treat; 2011 Nov; 130(2):517-29. PubMed ID: 21604156
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.
Qiu LX; Yao L; Mao C; Chen B; Zhan P; Yuan H; Xue K; Zhang J; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):543-7. PubMed ID: 20143154
[TBL] [Abstract][Full Text] [Related]
8. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.
Qiu LX; Yao L; Xue K; Zhang J; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):487-90. PubMed ID: 20135345
[TBL] [Abstract][Full Text] [Related]
9. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
Qiu LX; Yao L; Mao C; Yu KD; Zhan P; Chen B; Yuan H; Zhang J; Xue K; Hu XC
Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636
[TBL] [Abstract][Full Text] [Related]
10. TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects.
Qiu LX; Yao L; Mao C; Chen B; Zhan P; Xue K; Zhang J; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):563-7. PubMed ID: 20143152
[TBL] [Abstract][Full Text] [Related]
11. Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis.
Hu Z; Li X; Yuan R; Ring BZ; Su L
Breast Cancer Res Treat; 2010 Apr; 120(3):705-14. PubMed ID: 19657731
[TBL] [Abstract][Full Text] [Related]
12. The association between HSD17B1 Ser312Gly polymorphism and breast cancer risk: a meta-analysis including 31,053 subjects.
Yao L; Cao LH; Qiu LX; Yu L
Breast Cancer Res Treat; 2010 Sep; 123(2):577-80. PubMed ID: 20151320
[TBL] [Abstract][Full Text] [Related]
13. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies.
Lu PH; Wei MX; Si SP; Liu X; Shen W; Tao GQ; Chen MB
Breast Cancer Res Treat; 2011 Feb; 126(1):141-8. PubMed ID: 20665102
[TBL] [Abstract][Full Text] [Related]
14. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
[TBL] [Abstract][Full Text] [Related]
15. Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects.
Lu PH; Yang J; Li C; Wei MX; Shen W; Shi LP; Jiang ZY; Zhou N; Tao GQ
Breast Cancer Res Treat; 2011 Apr; 126(3):663-70. PubMed ID: 20809358
[TBL] [Abstract][Full Text] [Related]
16. The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis.
Yao L; Fang F; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Nov; 124(1):223-7. PubMed ID: 20204503
[TBL] [Abstract][Full Text] [Related]
17. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
Qiu LX; Yao L; Zhang J; Zhu XD; Zhao XM; Xue K; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500
[TBL] [Abstract][Full Text] [Related]
18. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
[TBL] [Abstract][Full Text] [Related]
19. P53 codon 72 polymorphism contributes to breast cancer risk: a meta-analysis based on 39 case-control studies.
Zhang Z; Wang M; Wu D; Wang M; Tong N; Tian Y; Zhang Z
Breast Cancer Res Treat; 2010 Apr; 120(2):509-17. PubMed ID: 19629678
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of an association of codon 72 polymorphisms of the p53 gene with increased endometrial cancer risk.
Gu Y; Zhou X; Zhang SL
Genet Mol Res; 2011 Oct; 10(4):3609-19. PubMed ID: 22057999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
